Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT03066648 |
Title | Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Novartis Pharmaceuticals |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA | NLD | GBR | FRA | ESP | DEU | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Massachusetts General Hospital | Boston | Massachusetts | 02114 | United States | Details | |
Oregon Health Sciences University Main Center | Portland | Oregon | 97239 | United States | Details | |
MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
Novartis Investigative Site | Melbourne | Victoria | 3004 | Australia | Details | |
Novartis Investigative Site | Helsinki | FIN 00290 | Finland | Details | ||
Novartis Investigative Site | Marseille | 13273 | France | Details | ||
Novartis Investigative Site | Dresden | 01307 | Germany | Details | ||
Novartis Investigative Site | Jena | 07740 | Germany | Details | ||
Novartis Investigative Site | Amsterdam | 1081 HV | Netherlands | Details | ||
Novartis Investigative Site | Barcelona | Catalunya | 08036 | Spain | Details | |
Novartis Investigative Site | Cardiff | CF4 4XN | United Kingdom | Details |